SCHEMBL32668872

SCHEMBL32668872

C=CCOCC[C@@H](C)OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
GBA1 P04062 1/20 0.35
C5AR1 P21730 1/20 0.35
CYP24A1 Q07973 1/20 0.35
CA2 P00918 3/20 0.35
CA9 Q16790 3/20 0.35
CA12 O43570 2/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 2/20 0.33
CA1 P00915 2/20 0.33
CA7 P43166 2/20 0.33
GAA P10253 2/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
TLR9 Q9NR96 1/20 0.33
MAPT P10636 1/20 0.33
CA4 P22748 1/20 0.33
HPGD P15428 1/20 0.33
CNR2 P34972 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32668768 1.00 ALDH1A1 (0.39) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL32668708 0.86 CA2 (0.40) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL32668915 0.86 CA2 (0.40) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL8940310 0.83 ALDH1A1 (0.35) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL8940478 0.82 ALDH1A1 (0.38) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL32668938 0.81 CA12 (0.36) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL27031968 0.81 CA12 (0.36) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL27144937 0.81 CA12 (0.36) ALDH1A1GBA1C5AR1CYP24A1CA2
SCHEMBL5830519 0.81 GBA1 (0.46) ALDH1A1GBA1CYP24A1CA2CA9
SCHEMBL5245093 0.81 GBA1 (0.46) ALDH1A1GBA1CYP24A1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034106-A1 Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics UNIV DARMSTADT TECH (DE) 2026-02-05 US disclosed
EP-4686495-A1 MACROCYCLIC LIGANDS FOR FK506-BINDING PROTEINS FOR TREATMENT OF DISEASES WITH IMPROVED CHARACTERISTICS Technische Universität Darmstadt (DE) 2026-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034106-A1 Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics FKBP3, FKBP2, FKBP1B ALDH1A1 4381/4885GBA1 3164/4885C5AR1 2329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.